Merck KGaA (FRA:MRK) has been given a €116.00 ($138.10) target price by investment analysts at Berenberg Bank in a report released on Wednesday. The brokerage presently has a “buy” rating on the healthcare company’s stock.

A number of other brokerages have also issued reports on MRK. DZ Bank AG reiterated a “neutral” rating on shares of Merck KGaA in a report on Monday, May 29th. Morgan Stanley set a €103.00 ($122.62) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a report on Monday, May 29th. Warburg Research set a €116.00 ($138.10) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a report on Monday, May 22nd. equinet AG set a €91.00 ($108.33) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a report on Saturday, May 20th. Finally, BNP Paribas set a €114.00 ($135.71) price objective on shares of Merck KGaA and gave the company a “buy” rating in a report on Saturday, May 20th. Thirteen research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of €108.38 ($129.02).

Shares of Merck KGaA (MRK) opened at 97.40 on Wednesday. The firm has a 50-day moving average of €93.25 and a 200 day moving average of €102.49. The firm has a market cap of €42.35 billion and a PE ratio of 25.39. Merck KGaA has a 52-week low of €89.00 and a 52-week high of €115.00.

COPYRIGHT VIOLATION WARNING: This article was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.dailypolitical.com/2017/09/15/merck-kgaa-mrk-given-a-116-00-price-target-by-berenberg-bank-analysts.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.